These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 38459552)
61. Is long-acting reversible contraceptive method use associated with HIV testing frequency in KwaZulu-Natal, South Africa and Lusaka, Zambia? Findings from the CUBE study. Beksinska M; Cartwright AF; Smit J; Kasaro M; Tang JH; Fawzy M; Maphumulo V; Chinyama M; Chabu E; Callahan R Contracept X; 2023; 5():100089. PubMed ID: 36718374 [TBL] [Abstract][Full Text] [Related]
62. Effectiveness of Cyclofem in the treatment of depot medroxyprogesterone acetate induced amenorrhea. Piya-Anant M; Koetsawang S; Patrasupapong N; Dinchuen P; d'Arcangues C; Piaggio G; Pinol A Contraception; 1998 Jan; 57(1):23-8. PubMed ID: 9554247 [TBL] [Abstract][Full Text] [Related]
66. Menstrual pattern changes from levonorgestrel subdermal implants and DMPA: systematic review and evidence-based comparisons. Hubacher D; Lopez L; Steiner MJ; Dorflinger L Contraception; 2009 Aug; 80(2):113-8. PubMed ID: 19631785 [TBL] [Abstract][Full Text] [Related]
67. Acceptability of an experimental intracervical device: results of a study controlling for selection bias. Shain RN; Ratsula K; Toivonen J; Lähteenmäki P; Luukkainen T; Holden AE; Rosenthal M Contraception; 1989 Jan; 39(1):73-84. PubMed ID: 2491982 [TBL] [Abstract][Full Text] [Related]
68. Effects of injectable contraception with depot medroxyprogesterone acetate or norethisterone enanthate on estradiol levels and menstrual, psychological and behavioral measures relevant to HIV risk: The WHICH randomized trial. Singata-Madliki M; Smit J; Beksinska M; Balakrishna Y; Avenant C; Beesham I; Seocharan I; Batting J; Hapgood JP; Hofmeyr GJ PLoS One; 2024; 19(3):e0295764. PubMed ID: 38530848 [TBL] [Abstract][Full Text] [Related]
69. Changes in unbound sex steroids and sex hormone binding globulin--binding capacity during oral and vaginal progestogen administration. Granger LR; Roy S; Mishell DR Am J Obstet Gynecol; 1982 Nov; 144(5):578-84. PubMed ID: 6890312 [TBL] [Abstract][Full Text] [Related]
71. An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs. Chi IC Contraception; 1991 Dec; 44(6):573-88. PubMed ID: 1773615 [TBL] [Abstract][Full Text] [Related]
72. Bone density in long term users of depot medroxyprogesterone acetate. Gbolade B; Ellis S; Murby B; Randall S; Kirkman R Br J Obstet Gynaecol; 1998 Jul; 105(7):790-4. PubMed ID: 9692421 [TBL] [Abstract][Full Text] [Related]
73. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives. Modesto W; Bahamondes MV; Bahamondes L Hum Reprod; 2014 Jul; 29(7):1393-9. PubMed ID: 24812309 [TBL] [Abstract][Full Text] [Related]
74. Pharmacodynamic studies on desogestrel administered alone and in combination with ethinylestradiol. Cullberg G Acta Obstet Gynecol Scand Suppl; 1985; 133():1-30. PubMed ID: 3161265 [TBL] [Abstract][Full Text] [Related]
75. Prevalence of Low Bone Mass and Osteoporosis in Long-Term Users of the Injectable Contraceptive Depot Medroxyprogesterone Acetate. Modesto W; Bahamondes MV; Bahamondes L J Womens Health (Larchmt); 2015 Aug; 24(8):636-40. PubMed ID: 26098552 [TBL] [Abstract][Full Text] [Related]
76. Rationale and design of a multi-center, open-label, randomised clinical trial comparing HIV incidence and contraceptive benefits in women using three commonly-used contraceptive methods (the ECHO study). Hofmeyr GJ; Morrison CS; Baeten JM; Chipato T; Donnell D; Gichangi P; Mugo N; Nanda K; Rees H; Steyn P; Taylor D; Gates Open Res; 2017; 1():17. PubMed ID: 29355224 [No Abstract] [Full Text] [Related]
77. Subclinical cardiovascular disease parameters after one year in new users of depot medroxyprogesterone acetate compared to copper-IUD. Cursino K; de Lima GA; de Nazaré Silva Dos Santos P; Pavin EJ; Bahamondes L; Fernandes A Eur J Contracept Reprod Health Care; 2018 Jun; 23(3):201-206. PubMed ID: 29671344 [TBL] [Abstract][Full Text] [Related]
78. Clinical chemistry in women treated with levonorgestrel implants (Norplant) or a TCu 200 IUD. Croxatto HB; Diaz S; Robertson DN; Pavez M Contraception; 1983 Mar; 27(3):281-8. PubMed ID: 6406139 [TBL] [Abstract][Full Text] [Related]
79. Reasons for contraceptive discontinuation in women 20-39 years old in New Zealand. Colli E; Tong D; Penhallegon R; Parazzini F Contraception; 1999 Apr; 59(4):227-31. PubMed ID: 10457866 [TBL] [Abstract][Full Text] [Related]
80. Clinical and hormonal effects of ethinylestradiol combined with gestodene and desogestrel in young women with acne vulgaris. Mango D; Ricci S; Manna P; Miggiano GA; Serra GB Contraception; 1996 Mar; 53(3):163-70. PubMed ID: 8689881 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]